Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: The impact of APOE and smoking

Psycho-Oncology

Volumn 23, Issue 12, 2014, Pages 1382-1390

  Ahles, Tim A ^a,b   Li, Yuelin ^a   McDonald, Brenna C ^b,c   Schwartz, Gary N ^d   Kaufman, Peter A ^d   Tsongalis, Gregory J ^d   Moore, Jason H ^d   Saykin, Andrew J ^c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NORRIS COTTON CANCER CENTER   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

APOE; Breast cancer; Chemotherapy; Cognition; Smoking

Indexed keywords

ANTINEOPLASTIC AGENT; APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; COGNITION; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NEUROPSYCHOLOGICAL TEST; PREVALENCE; SMOKING; WORKING MEMORY; BREAST NEOPLASMS; CASE CONTROL STUDY; COGNITION DISORDERS; GENETICS; LONGITUDINAL STUDY; MIDDLE AGED; PSYCHOLOGY;

ADULT; AGED; ANTINEOPLASTIC AGENTS; APOLIPOPROTEIN E4; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHEMOTHERAPY, ADJUVANT; COGNITION; COGNITION DISORDERS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SMOKING;

EID: 84915731609     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.3545     Document Type: Article

References (33)

1. Wefel JS, Vardy J, Ahles TA, Schagen S. International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in cancer patients. Lancet Oncol 2011;12:703-708.
2. Ahles TA, Root JC, Ryan EL. Cancer and cancer treatment associated cognitive change: an update on the state of the science. J Clin Oncol 2012;30:3675-3686.
3. Ahles TA. Brain vulnerability to chemotherapy toxicities. Psycho-Oncology 2012;21:1141-1148.
4. Ahles TA, Saykin AJ. Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 2007;7:192-201.
5. Ahles TA, Saykin AJ, McDonald BC, et al. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. J Clin Oncol 2010;28:4434-4440.
6. Schilder C, Seynaeve C, Beex LV, et al. Effects of tamoxifen and exemestane on cognitive function of postmenopausal patients with breast cancer: results from the neuropsychological side study of the Tamoxifen and Exemestane Adjuvant Multinational Trial. J Clin Oncol 2010;28:1294-1300.
7. Bookheimer S, Burggren A. APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging. Annu Rev Clin Psychol 2009;5:343-362.
8. Ahles TA, Saykin AJ, Noll WW, et al. The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy. Psycho-Oncology 2003;12:612-619.
9. Reitz C, Luchsinger J, Tang MX, Mayeux R. Effect of smoking and time on cognitive function in the elderly without dementia. Neurology 2005;65:870-875.
10. Sabia S, Kivimaki M, Kumari M, et al. Effect of apolipoprotein E 4 on the association between health behaviors and cognitive function in late midlife. Mol Neurodegeneration 2010;5:1-7.
11. Dufouil C, Tzourio C, Brayne C, et al. Influence of apolipoprotein E genotype on the risk of cognitive deterioration in moderate drinkers and smokers. Epidemiology 2000;11:280-284.
12. Carmelli D, Swan GE, Reed T, et al. The effect of apolipoprotein E4 in the relationships of smoking and drinking to cognition. Neuroepidemiology 1999;18:125-133.
13. Ahles TA, Saykin AJ, McDonald BC, et al. Cognitive function in breast cancer patients prior to adjuvant treatment. Breast Cancer Res Treat 2008;110:143-152.
14. The Psychological Corporation. Wechsler Abbreviated Scale of Intelligence. The Psychological Corporation: San Antonio, TX, 1999.
15. Delis DC, Kaplan E, Kramer JH. Delis-Kaplan Executive Function System. The Psychological Corporation: San Antonio, TX, 2001.
16. Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test - Second Edition: Adult Version Manual. The Psychological Corporation: San Antonio, TX, 2000.
17. The Psychological Corporation. WAIS-III Wechsler Adult Intelligence Scale - Third Edition: WMS-III Wechsler Memory Scale - Third Edition Updated Technical Manual. The Psychological Corporation: San Antonio, TX, 1997.
18. Fischer JS, Jak AJ, Kniker JE, et al. Multiple Sclerosis Functional Composite (MSFC) Administration and Scoring Manual. National Multiple Sclerosis Society: New York, 2001.
19. Lafayette Instrument. Grooved Pegboard: Instruction/Owner's Manual. Lafayette Instrument: Lafayette, IN, 2001.
20. Gordon M, McClure FD, Aylward GP. The Gordon Diagnostic System Instruction Manual and Interpretive Guide. Gordon Systems Inc.: Dewitt, NY, 1986.
21. Reymer W, Groenemeyer V, Van De Burg R, Kastelin J. Apolipoprotein E genotyping on agarose gels. Clin Chem 1995;41:1046-1047.
22. Flay BR, Miller TQ, Hedeker D, et al. The television, school, and family smoking prevention and cessation project. VIII. Student outcomes and mediating variables. Prev Med 1995;24:29-40.
23. Barnett AG, van der Pols JC, Dobson AJ. Regression to the mean: what it is and how to deal with it. Int J Epidemiol 2005;34:215-220.
24. Kenward MG, Roger JH. Small sample inference for fixed effects from restricted maximum likelihood. Biometrics 1997;53:983-997.
25. Brown H, Prescott R. Applied Mixed Models in Medicine. John Wiley& Sons: New York, 2006.
26. Littell RC, Milliken GA, Stroup WW, et al. SAS System for Mixed Models. SAS Institute, Inc.: Cary, NC, 1996.
27. van Duijn CM, Havekes LM, Van Broidkhoven C, et al. Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease. Br Med J 1995;310:627-631.
28. Small BJ, Rawson KS, Walsh E, et al. Catechol-o-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breast cancer survivors. Cancer 2011;117:1369-1376.
29. McDonald BC, Conroy SK, Ahles TA, et al. Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study. Breast Cancer Res Treat 2010;123:819-828.
30. McDonald BC, Conroy SK, Ahles TA, et al. Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional MRI study. J Clin Oncol 2012;30:2500-2508.
31. Jacobs E, D'Esposito M. Estrogen shapes dopamine-dependent cognitive processes: implications for women's health. J Neurosci 2011;31:5286-5293.
32. Slotkin TA. Nicotine and the adolescent brain: insights from an animal model. Neurotoxicol Teratol 2002;24:369-384.
33. Jim HSI, Phillips KM, Chait S, et al. Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. J Clin Oncol 2012;30:3578-3587.